Chemed Management

Management criteria checks 3/4

Chemed's CEO is Kevin McNamara, appointed in Aug 1994, has a tenure of 30.25 years. total yearly compensation is $12.63M, comprised of 12.7% salary and 87.3% bonuses, including company stock and options. directly owns 0.69% of the company’s shares, worth $58.43M. The average tenure of the management team and the board of directors is 24.5 years and 15.5 years respectively.

Key information

Kevin McNamara

Chief executive officer

US$12.6m

Total compensation

CEO salary percentage12.7%
CEO tenure30.3yrs
CEO ownership0.7%
Management average tenure24.5yrs
Board average tenure15.5yrs

Recent management updates

Recent updates

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

CEO Compensation Analysis

How has Kevin McNamara's remuneration changed compared to Chemed's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$302m

Jun 30 2024n/an/a

US$301m

Mar 31 2024n/an/a

US$283m

Dec 31 2023US$13mUS$2m

US$273m

Sep 30 2023n/an/a

US$245m

Jun 30 2023n/an/a

US$226m

Mar 31 2023n/an/a

US$240m

Dec 31 2022US$12mUS$1m

US$250m

Sep 30 2022n/an/a

US$262m

Jun 30 2022n/an/a

US$277m

Mar 31 2022n/an/a

US$267m

Dec 31 2021US$12mUS$1m

US$269m

Sep 30 2021n/an/a

US$308m

Jun 30 2021n/an/a

US$303m

Mar 31 2021n/an/a

US$329m

Dec 31 2020US$12mUS$1m

US$319m

Sep 30 2020n/an/a

US$271m

Jun 30 2020n/an/a

US$263m

Mar 31 2020n/an/a

US$231m

Dec 31 2019US$10mUS$1m

US$220m

Sep 30 2019n/an/a

US$209m

Jun 30 2019n/an/a

US$201m

Mar 31 2019n/an/a

US$205m

Dec 31 2018US$9mUS$1m

US$206m

Sep 30 2018n/an/a

US$206m

Jun 30 2018n/an/a

US$190m

Mar 31 2018n/an/a

US$113m

Dec 31 2017US$8mUS$1m

US$98m

Compensation vs Market: Kevin's total compensation ($USD12.63M) is above average for companies of similar size in the US market ($USD7.94M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


CEO

Kevin McNamara (70 yo)

30.3yrs

Tenure

US$12,625,106

Compensation

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director30.3yrsUS$12.63m0.69%
$ 58.4m
Michael Witzeman
VP, Controller12.5yrsUS$2.93m0.025%
$ 2.1m
Spencer Lee
Executive Vice President24.5yrsUS$3.37m0.13%
$ 11.3m
Thomas Hutton
VP & Director36.8yrsno data0.56%
$ 47.2m
Nicholas Westfall
Executive Vice President8.4yrsUS$4.71m0.041%
$ 3.4m
Lisa Reinhard
VP, Chief Administrative Officer & Secretary30yrsno datano data
Sherri Warner
Director of Investor Relationsno datano datano data
Brian Judkins
VP, Secretary & Chief Legal Officer4.3yrsno data0.0095%
$ 801.3k
Nathan McNamara
VP & Chief Strategy Officerno datano datano data

24.5yrs

Average Tenure

52.5yo

Average Age

Experienced Management: CHE's management team is seasoned and experienced (24.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director37.8yrsUS$12.63m0.69%
$ 58.4m
Thomas Hutton
VP & Director39.8yrsno data0.56%
$ 47.2m
Thomas Rice
Independent Director15.5yrsUS$278.27k0.040%
$ 3.4m
Sandra Laney
Director Emeritus15.5yrsUS$157.02kno data
Patrick Grace
Independent Director28.8yrsUS$308.60k0.022%
$ 1.8m
George Walsh
Independent Chairman29.8yrsUS$453.15k0.023%
$ 2.0m
Andrea Lindell
Independent Director16.5yrsUS$272.77k0.038%
$ 3.2m
Christopher Heaney
Independent Director4.5yrsUS$279.43k0.014%
$ 1.2m
Ron DeLyons
Independent Director4.5yrsUS$278.27k0.0093%
$ 782.0k
John Mount
Independent Director2.3yrsUS$278.27k0.0044%
$ 367.4k
Eileen McCarthy
Independent Director1.5yrsUS$238.52k0.0039%
$ 325.4k

15.5yrs

Average Tenure

70yo

Average Age

Experienced Board: CHE's board of directors are seasoned and experienced ( 15.5 years average tenure).